Starting July 2, 2013, the European Commission will require all Active Pharmaceutical Ingredient (API) manufacturers to meet EU current good manufacturing practice (CGMP) standards before importing products into the EU. The new regulations were passed in 2011, but countries from India to... Read More
The Thai pharmaceutical market is the largest in Southeast Asia, with a value of more than $4 billion in 2012. At its current rate of growth, it should more than double in size by 2020, when it is expected to reach a... Read More
On March 29, 2013 the Ministry of Health issued a Circular amending and supplementing the Law on Pharmacy 2005. Read More
Indonesia's pharmaceutical market is one of the fastest growing in Asia, expanding at an annual rate of 12.5 percent. It is currently worth $4.5 billion, about the same size as Taiwan's pharmaceutical market. But while Taiwan's economy is mature, Indonesia's is still... Read More
The pharmaceutical market in Malaysia is worth $3.2 billion, about three times the size of Singapore's market. It is growing rapidly, at a pace of 11 percent per year. As Malaysia's economy booms, spending on healthcare is up. The country's 28.9 million... Read More
The Philippines' market for pharmaceutical products is growing at its fastest pace in years, at about 13 percent annually. By 2014, experts predict that it will have a value of $4 billion. This would make the drug market in the Philippines almost... Read More
In its 2014 budget request, the US FDA is seeking an additional $10 million to increase its food and drug inspections in China. More than $4.7 million of the increase would go toward the drug inspection office. The China drug office hopes... Read More
Chinese officials are pushing for more deals from drug makers in an increasing effort to make healthcare more affordable. Mr. Zhu Chen, China’s former health minister, made it clear in an interview in April, 2013, that Pharmaceutical companies would need to lower... Read More
In 2007, India’s Department of Pharmaceuticals (DOP) formed the Committee on Price Negotiation for Patented Drugs. In February 2013, the Committee unveiled a new draft drug pricing policy that would affect granting of compulsory licenses for some manufacturers. Currently, compulsory licenses may... Read More
India makes a lot of their own APIs. However, in 2011, India imported $2.9 billion in Active Pharmaceutical Ingredients (APIs). In 2012, India API imports amounted to significantly more at $4.6 billion. Companies have said the steep increase in imports is to... Read More